Abbott | Juan Carlos Gaona H.
Abbvie | Camilo Gomez
Biogen | Christiano Silva
Besins | Laurena Magnoni
Boehringer | Marc Hasson
Bristol-Myers Squibb (BMS) | Gaetano Crupi
Grunenthal | Jun Celso Eguti
Janssen | Roy Benchimol
Merck | Pedro Galvis
MSD | Hugo Nisenbom
Novartis | Renato Carvalho
Novo Nordisk | Allan Finkel
Pfizer | Carlos Murillo
Roche | Patrick Daniel Eckert
Sanofi | Félix Scott
Takeda | Renata Campos


Allan Finkel (Novo Nordisk) | Vice-presidente
Carlos Murillo (Pfizer) | Vice-presidente substituto
Hugo Nisenbom (MSD) | Vice-presidente substituto
Renata Campos (Takeda) | Vice-presidente substituta
Patrick Daniel Eckert (Roche) | Vice-presidente substituto

Edivaldo Bardella (Roche)
Fabio Heleno (Bayer)
Fernando Ozeki (Boehringer)
Luis Eduardo Coimbra (Novartis)
Virginia Tavares (Sanofi)

Elizabeth de Carvalhaes
Controller


Comunicação Institucional
Jurídico e Compliance, Tatiane Schofield

Abbot
Abbvie
Aegerion
Alexion
Allergan
Amgen
Astellas
Astra Zeneca
Bago
Bayer
Besins
Biogen Idec
Biomarin
Biominas
BMS
Boehringer Ingelheim
Celgene
Chiesi
Daiichi Sankyo
Eisai
Ferring Farmaceuticals
Galderma
Ge
Gilead
Glenmark
Grunenthal
GSK
Ipsen
Janssen
LEO
Lilly
Lundbeck
MSD
Mundipharma
Novartis
Novo Nordisk
Pfizer
Pharma Praxis
PTC Therapeutics
Pierre Fabre
Roche
Sanofi Aventis
Sarepta Farmacêutica
Servier
Shire
Takeda
Teva
Theraskin
UCB
Vertex Pharmaceuticals
Zambon